p300 suppresses the transition of myelodysplastic syndromes to acute myeloid leukemia is a research paper published in JCI Insight (2021). On theSindex it has a DataRank of 0. It has been cited 19 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Leukemia & Lymphoma Society
Grant: 7017-18
NIH
Grant: R01CA166835,R01GM62437,K99GM124357
National Cancer Institute
Grant: 5R01CA166835,1P30CA240139
NIGMS NIH HHS
Grant: R37 GM062437
NIGMS NIH HHS
Grant: K99 GM124357
NCI NIH HHS
Grant: R01 CA166835
NCI NIH HHS
Grant: P30 CA240139
NIGMS NIH HHS
Grant: R01 GM062437
National Institutes of Health
Grant: 5R01CA166835-02
Targeting p300 and lysine acetylation in AML
National Institutes of Health
Grant: 5K99GM124357-03
p300/CBP and MOZ Acetyltransferase Function and Substrate Selectivity
National Institutes of Health
Grant: 3P30CA240139-02S3
The Sylvester Cancer Center Support Grant
National Institutes of Health
Grant: 5R01GM062437-08
Mechanisms & Inhibition of Histone Acetyltransferases
FWCI
2.23
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals